case_images: PMC4821138_01
case_images: Slit-lamp biomicroscopy image of the right eye. Adenoviral keratoconjunctivitis-related SEIs in the central part of the cornea.
case_images: cop-0007-0135-g01.jpg
case_images: PMC4821138_01_cop-0007-0135-g01.jpg
case_images: F1
case_images: Slit-lamp biomicroscopy revealed mild conjunctival hyperemia, several centrally located corneal SEIs (fig. 1), and superficial punctate epitheliopathy in the right eye.
case_images: IVCM image of the right eye. Subepithelial Langerhans cells with characteristic pseudopods (depth: 41 microm).
case_images: cop-0007-0135-g02.jpg
case_images: PMC4821138_01_cop-0007-0135-g02.jpg
case_images: F2
case_images: Langerhans cells with typical pseudopods were detected at the subepithelial nerve plexus level of the corneas of both eyes, predominantly in the right eye (fig. 2).
case_images: Slit-lamp biomicroscopy image of the right eye after the use of 0.05% CsA nanoemulsion formulation for 1 month. SEIs appear less active.
case_images: cop-0007-0135-g03.jpg
case_images: PMC4821138_01_cop-0007-0135-g03.jpg
case_images: F3
case_images: At the 1-month visit following initiation of the nanoemulsion formulation, her symptoms improved, SEIs appeared less active at slit-lamp biomicroscopy, and there was no corneal staining (fig. 3).
case_images: IVCM image of the right eye. No visible subepithelial Langerhans cells are present after 1 month of treatment with the 0.05% nanoemulsion formulation (depth: 40 microm).
case_images: cop-0007-0135-g04.jpg
case_images: PMC4821138_01_cop-0007-0135-g04.jpg
case_images: F4
case_images: IVCM did not reveal Langerhans cells anymore (fig. 4).